Your browser doesn't support javascript.
loading
Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.
Motwani, Shveta S; McMahon, Gearoid M; Humphreys, Benjamin D; Partridge, Ann H; Waikar, Sushrut S; Curhan, Gary C.
Afiliação
  • Motwani SS; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
  • McMahon GM; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
  • Humphreys BD; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
  • Partridge AH; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
  • Waikar SS; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
  • Curhan GC; Shveta S. Motwani, Gearoid M. McMahon, Sushrut S. Waikar, and Gary C. Curhan, Brigham and Women's Hospital; Shveta S. Motwani and Ann H. Partridge, Dana-Farber Cancer Institute; Shveta S. Motwani, Gearoid M. McMahon, Ann H. Partridge, Sushrut S. Waikar, and Gary C. Curhan, Harvard Medical School; Ga
J Clin Oncol ; 36(7): 682-688, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29320311
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Injúria Renal Aguda / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Injúria Renal Aguda / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article